Mark W Kieran

Dana-Farber Cancer Institute

$5,389,245

Attributed

$5,389,245

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.7M · FY2005–17

$2M$1.5M$1M$500K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

Funding mix

By agency

NIH$5,558,987 · 9

By mechanism

RC2$3,297,821 · 1

P50$1,365,896 · 2

U01$525,525 · 1

S10$339,484 · 4

M01$30,261 · 1

Top collaborators

No co-investigators on record.

Most similar at Dana-Farber Cancer Institute

Same institution · by research overlap

Elizabeth A Maher$5,123,370
Othon Iliopoulos$11,620,320
William G Kaelin$28,163,102

Others in their field

Top investigators on “Clinical Trials”

Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
Sonia M Thomas · Research Triangle Institute$700,865,642
David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
Bambra Strokes · Ppd Development Lp$526,656,217
Judith S. Currier · University Of California Los Angeles$504,273,077

Research focus

Clinical TrialsGliomaClinical ResearchCessation Of LifeSamplingBiochemicalMutationHuman SubjectPathway InteractionsNormal CellEnzymesMutantCellsBiologicalBrain NeoplasmsDesignFutureCooperative StudyChild (0-11)Neoplasm /Cancer TherapyPediatric Neoplasm /CancerClinical MaterialAstrocytesClinical Investigator